Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions

Cardiovascular Research

Volumn 89, Issue 1, 2011, Pages 234-243

  Tang, Eva H C ^a,b   Shimizu, Koichi ^a   Christen, Thomas ^a   Rocha, Viviane Z ^a   Shvartz, Eugenia ^a   Tesmenitsky, Yevgenia ^a   Sukhova, Galina ^a   Shi, Guo Ping ^a   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atherogenesis; Atherosclerosis; E prostanoid receptor 4; EP4 receptor; Inflammation

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E RECEPTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; CARDIOVASCULAR INFLAMMATION; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENOTYPE; IN VIVO STUDY; LIPID DIET; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHEMOKINE CCL2; CHEMOKINE CXCL10; DNA PRIMERS; FEMALE; INFLAMMATION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MODELS, CARDIOVASCULAR; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, LDL; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE;

EID: 78650449351     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq262     Document Type: Article

References (30)

1. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 2007;282: 11613-11617.
2. 2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 2002;277:44147-44154.
3. Minami M, Shimizu K, Okamoto Y, Folco E, Ilasaca ML, Feinberg MW et al. Prostaglan-din E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem 2008;183:9692-9703.
4. Regan JW. EP2 and EP4 prostanoid receptor signaling. Life Sci 2003;74:143-153.
5. Takayama K, Sukhova GK, Chin MT, Libby P. A novel prostaglandin E receptor 4-associated protein participates in anti-inflammatory signaling. Circ Res 2006;98: 499-504.
6. 2 receptor 4 activation in murine cardiac transplantation. Transplantation 2009;87:1645-1653.
7. 2 receptor EP4 improves cardiac function after myo-cardial ischaemia/reperfusion injury. Cardiovasc Res 2009;81:123-132.
8. 4. Circulation 2004;109:2462-2468.
9. Tang EHC, Shvartz E, Sukhova G, Shimizu K, Shi GP, Zheng C et al. Deletion of EP4 receptors on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. 2009; (submitted for publication).
10. 2-dependent plaque instability. Circulation 2001;104:921-927.
11. Cipollone F, Fazia ML, Iezzi A, Cuccurullo C, De Cesare D, Ucchino S et al. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol 2005;9: 1925-1931.
12. Babaev VR, Chew JD, Ding L, Davis S, Breyer MD, Breyer RM et al. Macrophages EP4 deficiency increases apoptosis and suppresses early atherosclerosis. Cell Metab 2008; 8:492-501.
13. Geng YJ, Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002;22:1370-1380.
14. Tabas I. Apoptosis and efferocytosis in mouse models of atherosclerosis. Curr Drug Targets 2007;8:1288-1296.
15. Seimon T, Tabas I. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J Lipid Res 2009;50:S382-S387.
16. Sanghi S, MacLaughlin EJ, Jewell CW, Chaffer S, Naus PJ, Watson LE et al. Cyclooxygenase-2 inhibitors: a painful lesson. Cardiovasc Hematol Disord Drug Targets 2006;6:85-100.
17. Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, Anderson PA et al. The prostaglandin receptor EP4 triggers remodeling of the cardiovascular system at birth. Nature 1997;390:78-91.
18. Fukuda D, Sata M, Ishizaka N, Nagai R. Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2008;28:90-96.
19. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003;111:897-906.
20. Sun J, Sukhova G, Yang M, Wolters PJ, MacFarlane LA, Libby P et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007;117:3359-3368.
21. Schneider F, Sukhova GK, Aikawa M, Canner J, Gerdes N, Tang SM et al. Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation 2008;117: 931-939.
22. Tanaka H, Sukhova GK, Libby P. Interaction of the allogeneic state and hypercholes-terolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb Vasc Biol 1994;14:734-745.
23. Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007;97:714-721.
24. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardeña G. Endothelial dysfunction, hemodynamic forces and atherogenesis. Ann N Y Acad Sci 2000;902: 230-239.
25. Schiller NK, Kubo N, Boisvert WA, Curtiss LK. Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2001;21:1674-1680.
26. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:1359-1366.
27. Ruwanpura SM, Noguchi K, Ishikawa I. Prostaglandin E2 regulates interleukin-1beta-induced matrix metalloproteinase-3 production in human gingival fibroblasts. J Dent Res 2004;83:260-265.
28. 2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J Biol Chem 2006;281:3321-3328.
29. 2 in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol 2005;67:1061-1069.
30. Yan M, Noguchi K, Ruwanpura SM, Ishikawa I. Cyclooxygenase-2-dependent prosta-glandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha. J Periodontol 2005;76:929-935.